Your cells use the CLTC gene to make part of clathrin, a protein that helps move materials in and out of cells and supports normal brain function. This gene plays an important role in how cells package and recycle important cargo. When the gene does not work properly, these transport steps can be disrupted. Some people with a pathogenic variant in the CLTC gene have a neurodevelopmental condition that may include developmental delay, low muscle tone, seizures, or movement differences.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or direct activities in the body. Some genes provide the code for proteins, which do much of the work inside cells. Other genes mainly regulate when certain processes happen, where they occur, and how active they are. Together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, and medications. To explore this subject in more detail, you can read more in the LearnHub.
Overview
CLTCGene function
What if the gene works
The CLTC gene helps cells make clathrin, a protein that forms tiny coated carriers for moving materials inside cells. This helps cells take in molecules from their surface and route proteins between internal compartments.
Risk
What if the gene does not work
Variants in the CLTC gene are linked to a neurodevelopmental condition that often affects learning, development, movement, and sometimes seizures or brain structure. Effects can range from milder developmental differences to more marked disability, depending on the variant.
Treatment
What does that mean for your treatment
No CLTC-specific treatment or management approach is currently established for pathogenic variants in the CLTC gene. The CLTC gene is being studied in cell transport pathways and in some cancer related gene fusions, but this has not yet changed treatment choices for people carrying a CLTC variant.
Conditions associated with CLTC
Gene function
What if the gene works
Small membrane packages help your cells move nutrients, signals, and worn out parts from one place to another. The CLTC gene makes a key part of the coat around many of these packages. Understanding what the CLTC gene does in the body helps explain how cells bring things in from their surface and sort them inside.
The CLTC gene helps cells pull selected materials in from their outer membrane. Its protein forms a curved coat around tiny transport bubbles, making uptake of nutrients and surface signals more controlled.
Inside cells, this protein helps package cargo and send it to the right compartment. That supports routine traffic between the cell surface, recycling areas, and the Golgi, a cell structure that prepares and ships proteins.
Many cells rely on the CLTC gene to remove used receptors from the surface and return some of them later. This helps keep cell messaging steady and prevents the membrane from becoming overcrowded.
This transport system also helps move materials toward compartments that break down and reuse cell contents. That supports orderly cleanup and lets cells recover useful building blocks for later use.
What is a variant?
Small differences in a gene’s DNA sequence are called genetic variants. They are common and help explain normal differences between people, including appearance, metabolism, and how the body responds to environmental influences. Many variants do not lead to any noticeable effect and are just part of natural genetic variation. At times, however, a variant can more substantially change how a gene functions and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Understanding how variants in the CLTC gene affect protein function starts with the clathrin heavy chain: changes can disrupt folding, assembly into its three part scaffold, or binding to partner proteins. Some variants partly weaken vesicle formation and cargo sorting, while more severe variants can lower protein levels or more strongly impair cell transport. In people with pathogenic variants in the CLTC gene, larger functional effects are often linked to earlier or broader neurodevelopmental features, although this varies.
How variants are linked to conditions
Pathogenic variants in the CLTC gene cause a rare CLTC-related neurodevelopmental condition, with CLTC gene variants linked to developmental delay and seizures in many affected children. People with this diagnosis may also have speech and learning difficulties, low muscle tone, movement or balance problems, and sometimes vision changes. Features vary widely, so support needs can differ from person to person.
A variant is not necessarily a diagnosis
Variants are a usual part of human biology and are common in the general population. Most do not directly affect health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For CLTC-related conditions, risk is mainly tied to whether a disease-causing change in the CLTC gene is present, and most known cases happen for the first time in the child rather than being caused by outside factors. There is not yet broadly confirmed evidence that diet, exercise, or other lifestyle factors increase or reduce this gene-related risk.
Inheritance of CLTC variants
CLTC gene variants are inherited in an autosomal dominant pattern for the main recognized CLTC related condition. This means a child can be affected if they inherit one altered copy of the CLTC gene from a parent, and each child of a parent who carries the variant has a 50% chance of inheriting it. Some CLTC gene variants happen as a new de novo change, so the affected person is the first in the family to have it. In practical terms, CLTC gene inheritance can involve either a parent-to-child pattern or a new change that was not inherited from either parent.
What does my CLTC result mean for my family?
For CLTC, the main known family pattern is dominant, which means a parent with the same disease-causing change can pass it on to a child. In many living with a CLTC-related condition, though, the change happened new in that person and was not inherited from either parent. Close relatives may sometimes be offered testing to see whether they also carry the same change.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for CLTC variants usually uses a blood or saliva sample. A lab reads the CLTC gene to look for changes that may help explain developmental or neurologic features, and results are interpreted with symptoms and family history. Testing can confirm a diagnosis in some people, but not every variant has a clear meaning.
When should I consider getting a genetic test?
Testing for the CLTC gene may be considered when a child has slower development than expected, low muscle tone, seizures, or unusual movement problems, especially if head growth is also different from expected. It can also be helpful when there is a family history of similar features or a known CLTC variant.
A genetic result is only one part of your health story
Genetic findings can provide useful insight, but how much they explain varies by the condition and the type of variant involved. Many factors, including lifestyle, environment, age, and medical history, also shape how the body works over time. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and makes the most sense alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas such as medication response, it can also help frame individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small inherited differences can change how the body breaks down a drug, moves it through the body, or responds to it at its target. Because of this, the same medication may work better for one person, have less effect in another, or cause side effects more easily in someone else. These differences are common and help explain why treatment response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can affect the way they respond to medicines. By looking at links between genes and specific drugs, it helps explain why the same treatment may not work the same way for everyone. For many medicines, genes can influence how the body handles a drug or how powerful its effects are. This information can support more personalized, well informed treatment choices. More detail is available in the LearnHub.
Drugs influenced by the CLTC gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or used, so questions about side effects, poor response, or new symptoms are best discussed with your doctor or pharmacist.
History
Scientists first identified clathrin in the 1970s while studying the coated pits and tiny transport sacs seen under electron microscopes. Over time, descriptions became more precise as researchers showed that the CLTC gene provides the main heavy chain of this long-studied cell transport protein. In the years that followed, CLTC drew added attention in cancer research because parts of the gene were found fused to other genes in some tumors. More recently, people with variants in the CLTC gene helped connect this research to human health, especially conditions affecting brain development and movement. These historical steps shaped today’s understanding of CLTC as both a core cell biology gene and a clinically relevant gene.